These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21803947)

  • 1. Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia.
    Bullen ML; Miller AA; Dharmarajah J; Drummond GR; Sobey CG; Kemp-Harper BK
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1405-14. PubMed ID: 21803947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae.
    Irvine JC; Favaloro JL; Widdop RE; Kemp-Harper BK
    Hypertension; 2007 Apr; 49(4):885-92. PubMed ID: 17309955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.
    Donzelli S; Fischer G; King BS; Niemann C; DuMond JF; Heeren J; Wieboldt H; Baldus S; Gerloff C; Eschenhagen T; Carrier L; Böger RH; Espey MG
    J Pharmacol Exp Ther; 2013 Feb; 344(2):339-47. PubMed ID: 23211362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity.
    Miller AA; Maxwell KF; Chrissobolis S; Bullen ML; Ku JM; Michael De Silva T; Selemidis S; Hooker EU; Drummond GR; Sobey CG; Kemp-Harper BK
    Free Radic Biol Med; 2013 Jul; 60():264-71. PubMed ID: 23459072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.
    Irvine JC; Cao N; Gossain S; Alexander AE; Love JE; Qin C; Horowitz JD; Kemp-Harper BK; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H365-77. PubMed ID: 23729209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness.
    Dautov RF; Ngo DT; Licari G; Liu S; Sverdlov AL; Ritchie RH; Kemp-Harper BK; Horowitz JD; Chirkov YY
    Nitric Oxide; 2013 Nov; 35():72-8. PubMed ID: 24012721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
    Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
    Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroxyl donors retain their depressor effects in hypertension.
    Irvine JC; Ravi RM; Kemp-Harper BK; Widdop RE
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H939-45. PubMed ID: 23851276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice.
    d'Uscio LV; Smith LA; Katusic ZS
    Stroke; 2001 Nov; 32(11):2658-64. PubMed ID: 11692031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia.
    Miller AA; De Silva TM; Judkins CP; Diep H; Drummond GR; Sobey CG
    Stroke; 2010 Apr; 41(4):784-9. PubMed ID: 20167907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO.
    Irvine JC; Kemp-Harper BK; Widdop RE
    Antioxid Redox Signal; 2011 May; 14(9):1615-24. PubMed ID: 20849324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does nitric oxide mediate the vasodilator activity of nitroglycerin?
    Kleschyov AL; Oelze M; Daiber A; Huang Y; Mollnau H; Schulz E; Sydow K; Fichtlscherer B; Mülsch A; Münzel T
    Circ Res; 2003 Oct; 93(9):e104-12. PubMed ID: 14551241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms.
    Favaloro JL; Kemp-Harper BK
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1274-80. PubMed ID: 19252101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid Arteries.
    Li JC; Velagic A; Qin CX; Li M; Leo CH; Kemp-Harper BK; Ritchie RH; Woodman OL
    Front Pharmacol; 2020; 11():585740. PubMed ID: 33716721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral vascular dysfunction during hypercholesterolemia.
    Kitayama J; Faraci FM; Lentz SR; Heistad DD
    Stroke; 2007 Jul; 38(7):2136-41. PubMed ID: 17525390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
    Salvemini D; Pistelli A; Anggard E
    Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoprotective Actions of Nitroxyl (HNO): A Story of Sibling Rivalry.
    Kemp-Harper B
    J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S13-S18. PubMed ID: 34840263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects.
    Anfossi G; Russo I; Massucco P; Mattiello L; Trovati M
    Thromb Res; 2003 Apr; 110(1):39-46. PubMed ID: 12877907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.